Company Performance Metrics
- Tomasz Konopczynski: CEO, AI specialist
- Adrian Korbecki: COO & CMO, Medical Expert
Hetalox is a medical technology company that provides artificial intelligence (AI) solutions for advanced assessment and analysis of brain MRI studies.
Our software enables precise segmentation of the brain and determination of the volume of individual brain structures, utilizing standard atlases such as the Desikan-Killiany and Destrieux atlases.
Additionally, we provide cortical thickness analysis and other volumetric parameters including white and gray matter volume, along with cortical surface analysis.
We also offer segmentation and volumetric assessment of white matter hyperintensities (WMH), which is essential for monitoring patients with multiple sclerosis and other neurological disorders. Apart from segmenting WMH lesions on FLAIR sequences, we can analyze hypointense areas on T1-weighted 3D images, which is significant for various research purposes in neuroimaging.
At the heart of Hetalox's offerings lie its exclusive proprietary AI algorithms, which drive innovation and precision in medical technology. Supported by a distinct dataset and a seasoned team of professionals, Hetalox ensures cutting-edge solutions for advanced healthcare needs.